Eduardo Couchonnal

Medication Adherence and Relevance of the SPUR Behavioural Diagnostic Tool in the Management of Patients with Wilson’s Disease: The WilSPUR Study

Olivier Guillaud, Eduardo Couchonnal, Rodolphe Sobesky, Claire Vanlemmens et autres

Medication Adherence and Relevance of the SPUR Behavioural Diagnostic Tool in the Management of Patients with Wilson’s Disease: The WilSPUR Study

Olivier Guillaud, Eduardo Couchonnal, Rodolphe Sobesky, Claire Vanlemmens et autres

fr, gb (code pays fourni par la source)

THU-275 Understanding Wilson disease beyond traditional phenotypes: cross-sectional analysis of study entry data from an international registry (iWilson)

Marina Berenguer, Zoe Mariñó, Emmanuel Tsochatzis, Piotr Socha et autres

Simplifying Urinary Copper Monitoring in Wilson Disease. Clinical Utility of Shortened and Spot Urine Collections

François Parant, Abdelouahed Belmalih, Amandine Perret, Chloé Laurencin et autres

Management of Wilson disease across Europe: an international physician-oriented survey by the ERN-RARE Liver group

Frederik Teicher Kirk, Karina Stubkjær Rewitz, Zoe Mariñó, Eduardo Couchonnal et autres

dk, nl, es, fr, be, us, gb, ro, de, pl (code pays fourni par la source)

Results of the up-titration phase of the UNITED study, an open label, multicenter, prospective study to characterize the pharmacokinetics and pharmacodynamics of trientine dihydrochloride and to investigate the efficacy and safety in Wilson disease patients

Isabelle Mohr, Anna Członkowska, Piotr Socha, Aurélia Poujois et autres

de, pl, fr, gb, dk (code pays fourni par la source)

SAT-388 Integrated PK-PD model relating serum copper concentrations, urinary copper clearance and trientine pharmacokinetics in Wilson disease: initial insights from the UNITED study

Peter Vis, Esmée Vendel, Isabelle Mohr, Anna Członkowska et autres

SAT-392 Profiling patients with Wilson’s disease using a behavioral diagnostic tool (Observia SPUR™): insights into adherence challenges and personalized care strategies

Rodolphe Sobesky, Claire Vanlemmens, Eduardo Couchonnal, Gersende Faton et autres

SAT-353-YI Management of Wilson disease across europe: an international physician-oriented survey by the ERN-RARE liver group

Frederik Teicher Kirk, Karina Stubkjær Rewitz, Wiebke Papenthin, Zoe Mariñó et autres

SAT-391 Switching from zinc salts to Trientine Tetrahydrochloride in Wilson disease: the ZICUP study

Dominique Debray, Rodolphe Sobesky, Michaël Obadia, Nouzha Oussedik‐Djebrani et autres

SAT-367 UNITED study: results of the up-titration phase of an open label, multicenter, prospective study to characterize the pharmacokinetics and pharmacodynamics of trientine dihydrochloride and to investigate the efficacy and safety in Wilson disease patients

Isabelle Mohr, Anna Członkowska, Piotr Socha, Aurélia Poujois et autres

SAT-343 Population pharmacokinetic (PK) model describing the variability of trientine pharmacokinetics in Wilson disease patients in the UNITED study

Esmée Vendel, Peter Vis, Isabelle Mohr, Anna Członkowska et autres